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Insulin-like growth factor 1 (IGF-1) is a potent enhancer 
of tissue regeneration, and its overexpression in muscle 
injury leads to hastened resolution of the inflammatory 
phase. Here, we show that monocytes/macrophages 
constitute an important initial source of IGF-1 in muscle 
injury, as conditional deletion of the IGF-1 gene spe-
cifically in mouse myeloid cells (φIGF-1 CKO) blocked 
the normal surge of local IGF-1 in damaged muscle 
and significantly compromised regeneration. In injured 
muscle, Ly6C+ monocytes/macrophages and CD206+ 
macrophages expressed equivalent IGF-1 levels, which 
were transiently upregulated during transition from the 
inflammation to repair. In injured φIGF-1 CKO mouse 
muscle, accumulation of CD206+ macrophages was 
impaired, while an increase in Ly6C+ monocytes/macro-
phages was favored. Transcriptional profiling uncovered 
inflammatory skewing in φIGF-1 CKO macrophages, 
which failed to fully induce a reparative gene program 
in vitro or in vivo, revealing a novel autocrine role for 
IGF-1 in modulating murine macrophage phenotypes. 
These data establish local macrophage-derived IGF-1 as 
a key factor in inflammation resolution and macrophage 
polarization during muscle regeneration.
Received 15 October 2014; accepted 8 April 2015; advance online  
publication 19 May 2015. doi:10.1038/mt.2015.66
INTRODUCTION
Although the regenerative capacity of injured skeletal muscle is 
relatively robust due to an abundant muscle progenitor cell pool, 
more sustained damage in cases of major tissue trauma or progres-
sive degenerative disease compromises muscle healing and leads 
to severe physical disability. Impaired resolution of inflammation 
in damaged muscle tissues poses a major impediment to regenera-
tion, leading to fibrotic scar formation and loss of functionality. 
Thus, modulation of the inflammatory response in muscle dam-
age or disease represents a promising therapeutic approach.
Macrophages are central regulators of inflammation in tissue 
injury. Heterogeneity and plasticity are macrophage hallmarks: 
maturation and differential activation (polarization) of monocytes 
infiltrating the damaged muscle generates functionally diverse 
macrophage subpopulations, which act in a coordinated and bal-
anced manner to mediate the tissue repair process.1,2 For simplic-
ity, these are often categorized as either M1 or M2 based on the 
Th1/Th2 classification system although in vivo macrophages dem-
onstrate a spectrum of phenotypes which are dynamic and gener-
ated from exposure to combinations of stimuli in varied tissue and 
disease environments. Classically activated (M1) macrophages 
are induced by inflammatory cytokines such as interferon gamma 
(IFNγ) and in turn produce potent inflammatory cytokines and 
reactive oxygen intermediates. In the context of murine muscle 
injury, these macrophages amplify inflammatory signals, recruit 
additional inflammatory cells, phagocytose tissue debris, and 
apoptotic neutrophils, and produce cytokines that activate muscle 
progenitor (satellite) cells.1,3 Like their monocyte precursors, they 
express high levels of Ly6C. Later stages of regeneration are domi-
nated by macrophages with anti-inflammatory and promyogenic 
functions, often collectively referred to as M2 or alternatively 
activated. Human M2 polarized macrophages promote myoblast 
fusion and the growth of myofibers in vitro.3 These immunomod-
ulatory macrophages suppress inflammation by producing IL-10 
and TGFβ, promoting remodeling of the extracellular matrix, and 
stimulating angiogenesis.4 Depletion of macrophages at late stages 
of repair also reduce myofiber growth,5 suggesting they produce 
cytokines and growth factors that support myogenesis.3,6 In the 
mouse, these muscle macrophages are similar to other M2 mac-
rophages in their wound-healing and immunosuppressive func-
tions. However, they are heterogeneous, with fractional expression 
of M2 surface markers CD206, CX3CR1, and CD163,1,5,7 mark-
ers that are more broadly represented on macrophages present 
in other tissues and diseases.8 These markers can also be highly 
expressed on resident populations. Further work is therefore 
needed to fully characterize the macrophage phenotypes in rest-
ing and regenerating muscle.
The regulation of macrophage polarization is a complex pro-
cess involving multiple cellular effectors and intracellular path-
ways. In acute injury, activated macrophages are sequentially 
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recruited with the inflammatory M1 population preceding the 
pro-regenerative M2 population. In damaged muscle, the M1 
population must be tightly regulated as it releases inflammatory 
cytokines and reactive oxygen species, causing myofiber lysis,9 and 
exacerbating injury. Indeed, prolongation of the M1 phase due to 
abrogation of M2 polarization profoundly affects regeneration,10 
while the administration of cytokines such as IL-10 to deactivate 
the M1 macrophage population reduces pathology in mouse mus-
cular dystrophy models.11 Thus, timely resolution of the M1 phase 
and transition to M2 macrophages is critical to the outcome of 
tissue damage: dysregulation of this process may underlie more 
complex muscle diseases and contribute to pathology as well as 
prevention of repair.
Insulin-like growth factor 1 (IGF-1) is a peptide hormone that 
mediates proliferation, differentiation, and survival upon binding 
its receptor, which is expressed by all cells. The actions of IGF-1 
in myogenesis are well defined. In vitro, it promotes both prolif-
eration and differentiation of myoblasts, induces myofiber hyper-
trophy, and protects from atrophy. In vivo, IGF-1 also increases 
myoblast proliferation12 and myofiber protein synthesis.13 These 
functions are essential to the development and maintenance of 
skeletal muscle, demonstrated by disruption of IGF-1 signaling 
in postnatal myofibers resulting in severe hypoplasia,14 whereas 
supplemental IGF-1 induces muscle hypertrophy15 and protects 
against age-related atrophy.16
IGF-1 also plays an important role in muscle regeneration. It 
is strongly upregulated following exercise or injury and reduced 
IGF-1 levels correlate to poor repair.6,17 Distinct IGF-1 propep-
tides differ in their N terminal signal peptides (class 1 or class 2) 
and C-terminal E-peptides generated by alternative splicing (Ea 
and Eb; Figure 1). Eb and Ea peptide-containing IGF-1 propep-
tides are sequentially produced in response to stretch injury,18 
and in vitro evidence has suggested distinct actions for the two 
propeptides (mitogenic versus differentiative).19,20 Transgenic or 
viral administration of IGF-1Ea propeptide enhances the repair 
process and hastens the restoration of contractile function,21 
increasing myofiber hypertrophy and accelerating the course of 
inflammation.21,22
Endogenous tissue IGF-1 is expressed by satellite cells, myo-
fibers, fibroblasts, endothelial cells, and inflammatory cells. 
Macrophages are the predominant inflammatory cells involved 
in skeletal muscle repair and abrogation of their migration to the 
site of injury results in reduced muscle IGF-1 levels.6 Thus, infil-
trating macrophages have been proposed as an important source 
of IGF-1 in regenerating skeletal muscle.6,23 Indeed in the kidney, 
an increase in macrophage presence caused by administration 
of macrophage colony-stimulating factor (MCSF) was associ-
ated with higher tissue IGF-1 levels and enhanced regeneration 
after ischemia/reperfusion injury24 and in the injured lung, IGF-1 
localizes to Arginase 1–positive M2 macrophages.25 In vitro, mac-
rophages also express significant quantities of IGF-1 propeptides 
in murine26 and human macrophages,27 upregulated by stimula-
tion with M2-polarizing stimuli IL-4, IL-13, or MCSF.
Here, we identify both Ly6C+ inflammatory monocytes/mac-
rophages and CD206+ macrophages as early sources of local, tran-
sient IGF-1, required for efficient skeletal muscle repair in vivo. 
IGF-1 expression by macrophages also modulates their own 
transition to a pro-repair phenotype through an autocrine loop 
which limits inflammation and promotes muscle reconstruction. 
We further delineate the IGF-1Ea propeptide as the active isoform 
in muscle regeneration. Modulation of macrophage phenotype 
by IGF-1 sheds new light on basic mechanisms of inflammation 
control in muscle injury and presents a therapeutically relevant 
intervention point for promoting effective tissue regeneration.
RESULTS
A transient surge in macrophage IGF-1 expression at 
the transition from inflammation to repair
In the setting of cardiotoxin (CTX)-injured skeletal muscle, IGF-1 
expression is induced in multiple resident cell types including 
myoblasts, endothelial cells, and fibroblasts, reaching highest lev-
els at day 10 postinjury (Supplementary Figure S1). We compared 
the dynamics of IGF-1 expression in CTX-injured mouse muscle 
and infiltrating macrophages and correlated IGF-1 levels to the 
accumulation of macrophage populations (Figure 2). Monocytes/
macrophages isolated from injured muscle were distinguished 
by Ly6C and CD206 expression, as illustrated in Figure 2b and 
Supplementary Figure S2a. The CD45+CD11b+F4/80+Ly6C+ 
cells also contain monocytes, and we refer to them as inflam-
matory Ly6C+ monocytes/macrophages, while we refer to the 
CD45+CD11b+F4/80+CD206+ cells as CD206+ macrophages. 
Consistent with previous studies,5,28 Ly6C+ inflammatory mono-
cytes/macrophages were observed in injured muscle during the 
first days after injury, reaching peak numbers at day 2 (Figure 2a), 
whereas CD206+ macrophages increased significantly at day 5 
as the Ly6C+ population declined. By day 10, almost all macro-
phages were CD206+; however, the overall number of macro-
phages in the muscle decreased concomitant with the resolution 
of inflammation.
High IGF-1 production has been associated with M2 mac-
rophage phenotypes, modeled in vitro by stimulation with IL-4 
and IL-13 causing a strong upregulation of IGF-1 propeptides in 
murine26 and human macrophages.27 Using probes that distinguish 
between IGF-1Ea and IGF-1Eb propeptide transcripts, we revealed 
temporally distinct expression patterns in whole  CTX-injured 
muscle which we compared to expression in macrophages 
 fluorescence activated cell sorted (FACS)-isolated from injured 
muscle (Figure 2c). IGF-1Ea expression was strongly upregulated 
at day 5 in both Ly6C+ and CD206+ cells (21-fold and 18-fold, 
respectively) but effectively suppressed in both populations by day 
10, when it remained elevated in whole muscle samples, presum-
ably due to expression in fibroblasts and other resident cells at 
this time point (Supplementary Figure S1). Isolated Ly6C+ and 
CD206+ populations expressed lower levels of IGF-1Eb transcripts 
at 2 days after injury, increasing at day 5 (ninefold and threefold 
for Ly6C+ and CD206+, respectively) and then declining at day 10. 
Thus, transient expression of IGF-1Ea in macrophages correlates 
with CD206+ macrophage accumulation in regenerating muscle.
The IGF-1Eb propeptide has been implicated in muscle growth 
and differentiation.19 The upregulation of IGF-1Eb propeptide 
observed during muscle regeneration prompted us to examine 
the effects of IGF-1Eb ablation on muscle repair by generating 
 IGF-1Eb knockout (KO) mice, driving deletion of a floxed exon 5 
allele (Figure 1) crossed into a CMV Cre mouse line. The resulting 
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offspring were born in Mendelian ratios, developed normally, and 
lacked an overt phenotype. IGF-1Eb KO mice showed no obvious 
abnormalities in muscle repair after CTX injury (Supplementary 
Figure S3), indicating that the IGF-1Eb propeptide is dispensable 
for muscle regeneration.29
MCSF is a strong positive regulator of IGF-1 in macrophages30 
and administration of MCSF during ischemic kidney injury 
increased tissue IGF-1 levels,24 suggesting that it regulates mac-
rophage IGF-1 expression during repair. We therefore compared 
IGF-1 expression kinetics to those of MCSF in the same samples 
(Figure 2d). MCSF mRNA was induced by 2 days after injury as 
was IGF-1; however, expression did not further increase at 5 days 
when we observed the peak of IGF-1.
In summary, monocytes/macrophages contribute significantly 
to IGF-1 levels in skeletal muscle during the initial stages of regen-
eration (days 2–5) but not during the later phase (day 10). IGF-1 
expression patterns are similar in Ly6C+ and CD206+ mono-
cyes/macrophages, suggesting that the regulation of monocye/
macrophage IGF-1 propeptide expression is related to the stage 
of muscle repair rather than to the polarization state. Indeed, the 
upregulation in monocye/macrophage expression of IGF-1Ea 5 
days after injury correlates with the transition from inflamma-
tion to regeneration, suggesting a role for  monocye/macrophage-
derived IGF-1 at this time.
Impaired muscle regeneration in the absence of 
monocye/macrophage-derived IGF-1
To determine the importance of monocye/macrophage-derived 
IGF-1Ea expression in muscle repair, we produced a  monocye/
macrophage-restricted knockout of the IGF-1 gene by cross-
ing a mouse carrying a floxed exon 3 in the IGF-1 gene locus 
(encoding the main body of the protein, Figure 1)31 with the lyso-
zyme M (LysM) Cre line that expresses Cre in the myeloid lin-
eage.32,33 Substantial recombination and deletion of IGF-1 exon 3 
in monocytes and macrophages was confirmed by qPCR on cells 
freshly isolated from injured muscle as well as bone marrow–
derived macrophage (BMM) cultures (Figure  3a). To confirm 
the specificity of deletion, we measured LysM and Cre expres-
sion in myoblasts, endothelial cells, inflammatory cells, and all 
remaining cells isolated from injured muscle (Supplementary 
Figure S4a,b). As expected LysM and Cre expression was 
restricted to the inflammatory cell fraction, although very minor 
expression was detected in the fraction negative for all markers 
 (CD45-α7β1-CD31-) likely to be fibroblasts. We measured IGF-1 
expression in this negative fraction (Supplementary Figure S4d) 
but did not observe a significant reduction in IGF-1 transcripts 
in LysMcre/+;IGF-1 Exon 3Flox/Flox (φIGF-1 CKO) compared to IGFFl/
Fl controls. Homozygous conditional φIGF-1 CKO mice were not 
born in Mendelian ratio (of 195 pups born, only 4.6% were φIGF-1 
CKOs when 25% was expected), underscoring an important role 
for IGF-1 in embryonic myeloid lineages. Surviving homozygotes 
had slightly reduced serum IGF-1 levels (78.2% of wild-type lev-
els; Supplementary Figure S5a); however, φIGF-1 CKO homozy-
gous neonates grew and developed normally, and no differences 
were observed in organ weights compared to littermate controls 
(Supplementary Figure S4b,c). No abnormalities were detected 
in the ratios of white blood cells present in peripheral blood, nor 
in Ly6C+ and Ly6C- monocyte populations under homeostatic 
conditions (Supplementary Figure S5d–f).
Quantitative RT-PCR for IGF-1 transcription was per-
formed on quadricep muscles at 0, 2, 5, and 10 days after CTX-
induced injury on IGFFl/Fl and φIGF-1 CKO mice (Figure 3b). In 
Figure 1  Structure of the rodent IGF-1 gene. The IGF-1 gene is comprised of six exons and five introns. Exons 3 and 4 encode the mature pro-
tein. Differential splicing on the 3′-end of the gene gives rise to a short Ea-peptide (dark gray box) when exon 5 is spliced out (35aa) and a longer 
Eb-peptide (light gray box), when exon 5 is included. IGF-1 propeptides contain either the Ea- or the Eb-peptide, which can be cleaved to produce 
the mature IGF-1 protein. Regions spanning exon 3 and exon 5 deleted in φIGF-1 CKO mice (ΔIGF-1) and IGF-1Eb KO (ΔIGF-1Eb), respectively, are 
indicated.
SP1 SP2 SP B C A D E E E
Exon 1 Exon 2 Exon 3 Exon 4 Exon 5 Exon 6
IGF-1 gene
B C A D EbIGF-1 Eb
∆IGF-1 ∆IGF-1 Eb
B C A D EaIGF-1 Ea
41 aa
35 aa
B C A D
70 aa
IGF-1  propeptides
Mature IGF-1
Molecular Therapy vol. 23 no. 7 jul. 2015 1191
© The American Society of Gene & Cell Therapy
Macrophage-derived IGF-1 Regulates Muscle Repair
comparison to IGFFl/Fl muscle, upregulation of IGF-1 transcript 
levels in φIGF-1 CKO muscle was abrogated at 2 and 5 days after 
injury but returned to normal levels by 10 days. Since LysM Cre 
is expressed by neutrophils as well as monocytes and macro-
phages,32,33 we cannot exclude the possibility that this cell type 
contributes to IGF-1 production during the first 24 hours postin-
jury when it is present in high numbers.6 However, monocytes 
and macrophages predominate during the peak of IGF-1 expres-
sion at 2 and 5 days after injury.
Histological analysis of CTX-injured tibialis anterior (TA) 
muscles showed comparable fiber necrosis, tissue dysmorphol-
ogy and inflammatory infiltrates in φIGF-1 CKO and IGFFl/Fl 
controls 2 days after injury (Figure 3c). By day 5, φIGF-1 CKO 
muscles displayed impaired regeneration, as nascent myofibers 
were substantially smaller than those observed in control muscles 
(Figure 3c). The difference was even more evident 10 days after 
injury, when φIGF-1 CKO muscles retained broader interstitial 
spaces, fat deposits, and had smaller fibers compared to IGFFl/Fl 
Figure 2 The surge in monocyte/macrophage IGF-1 production correlates with transition from inflammatory to repair macrophage pheno-
types following muscle injury. (a) Kinetics of Ly6C+ monocyte/macrophage and CD206+ macrophage accumulation in the quadricep muscle is 
presented at various time points after CTX injury in WT muscle. (b) For analysis of monocyte/macrophage subpopulations, mononuclear cells were 
isolated from quadricep muscles and analyzed by flow cytometry. Monocytes/macrophages were defined as CD45+CD11b+F4/80+ as shown in the 
first two images, and then, the inflammatory monocyte/macrophages were discriminated by Ly6C expression while a mature reparative macrophage 
population was defined by CD206 expression. Isotype controls were used as negative gating controls to define positive signals and are shown in 
Supplementary Figure S2. (c) IGF-1Ea and IGF-1Eb propeptide expression was determined by qPCR of whole muscle (black bars) as well as Ly6C+ 
(red bars) and CD206+ (blue bars) macrophages isolated from CTX-injured muscle at 0, 2, 5, and 10 days after CTX injury. (d) MCSF expression 
measured by qPCR in whole muscle at 0, 2, 5, and 10 days after CTX injury. n = 7–8. Data represent mean ± SEM. CTX, cardiotoxin; WT, wild type.
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Figure 3 Monocyte/macrophage-derived IGF-1 regulates muscle regeneration. (a) Myeloid deletion of IGF-1 was confirmed in φIGF-1 CKO mice 
by qPCR of monocytes and macrophages isolated from CTX-injured muscle as well as BMM cultures. Monocytes (CD45+CD11b+F480lo/-Ly6G-) 
and macrophages (CD45+CD11b+F480hi) isolated from injured φIGF-1 CKO muscle were compared to IGF-1Fl/Fl controls, n = 4. BMM prepared 
from φIGF-1 CKO and IGF-1Fl/Fl controls were stimulated with IL-4 to induce IGF-1 upregulation and mRNA levels measured after 12 hours (n =4). 
(b) Quadricep muscles of control IGF-1Fl/Fl and φIGF-1 CKO mice were injured with CTX and analyzed for IGF-1 expression by qPCR 0, 2, 5, and 10 
days after injury. Data represent mean ± SEM of four muscles. (c) Representative images of Trichrome-stained TA muscle sections from IGF-1Fl/Fl and 
φIGF-1 CKO mice 0, 2, 5, and 10 days after CTX injury. Bar = 100 μm. (d–f) Quantification of regeneration in the TA at 5 and 10 days postinjury. 
(d) Regeneration parameters at 5 days after injury; the mean CSA of regenerating (centrally-nucleated) myofibers, the distribution plot of myofiber 
CSAs and number of fibers per unit area. (e) Myoblasts were isolated from injured muscle 5 days after injury using flow cytometry, identified as 
shown in Supplementary Figure S1a. The data are presented as the number of myoblasts per milligram of muscle in IGF-1Fl/Fl and φIGF-1 CKO 
mice. (f) The mean CSA, CSA distribution plot, and number of fibers per square millimeter of section at 10 days after injury. At the very right, the 
number of nuclei per myofiber is shown for the 10-day time point. *P ≤ 0.05; **P ≤ 0.01 compared to IGF-1Fl/Fl control by Mann–Whitney test. BMM, 
bone marrow–derived macrophages; CSA, cross-sectional area; CTX, cardiotoxin; Mφ, macrophage; TA, tibialis anterior.
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muscle (Figure 3c). Quantitation of regenerating (centrally nucle-
ated) fiber cross-sectional area (CSA) revealed a 40% reduction 
in average φIGF-1 KO CSA at the 5-day time point, while the 
number of fibers per square millimeter was increased, indicat-
ing a problem in fiber growth rather than formation of myotubes. 
Analysis of φIGF-1 CKO CSA distribution showed a general shift 
toward smaller fibers (Figure  3d). Analysis of activation and 
expansion of myoblasts at day 5 by flow cytometric measurement 
of α7β1 integrin+ cells revealed that φIGF-1 CKO mice had only 
half the number of myoblasts per milligram of muscle when com-
pared with IGFFl/Fl controls (Figure 3e). By 10 days, the average 
CSA of φIGF-1 CKO muscle increased (792 μm2 compared to 457 
μm2), although still 36% lower than the IGFFl/Fl control (Figure 3f) 
with increased interstitial space taking the place of new fibers. 
Although the regenerating φIGF-1 CKO fibers appeared unable 
to expand in area, they had a greater number of nuclei associated 
with each fiber than controls (Figure 3f), suggesting the process of 
myoblast fusion was not disrupted.
These data demonstrate that monocytes/macrophages are an 
important source of IGF-1 at the initial stage of damage and during 
the transition to the reparative phase. Although it was not possi-
ble to specifically delete the IGF-1Ea propeptide without affecting 
IGF-1Eb propeptide expression due to the exon structure of the 
IGF-1 gene, absence of the IGF-1Eb peptide did not affect muscle 
repair (Supplementary Figure S3), and we therefore deduce that 
the regenerative deficit in the φIGF-1 CKO mice derives princi-
pally from absence of the IGF-1Ea propeptide. Ablation of the 
surge in IGF-1Ea expression disrupts regeneration, affecting myo-
blast expansion and myofiber growth, the consequences of which 
are still apparent by 10 days after injury when macrophages are no 
longer present in the injury site.
Reduced accumulation of CD206+ macrophages in 
injured φIGF-1 CKO muscle
IGF-1 has a well-documented role in myogenesis, and the reduced 
levels of IGF-1 in the φIGF-1 CKO muscle likely impair regen-
eration in part because of compromised paracrine signaling in 
the myoblasts and newly formed fibers.34 This growth factor also 
acts by autocrine signaling, which prompted us to examine the 
absence of IGF-1 on the myeloid population itself.
Analysis of myeloid cell infiltration in CTX-injured IGFFl/Fl 
control and φIGF-1 CKO muscles revealed increased monocyte 
(CD45+CD11b+Ly6G-Ly6Chi) recruitment to the muscle (42% 
when compared to IGFFl/Fl controls) but did not affect accumula-
tion of neutrophils (CD45+CD11b+Ly6G+Ly6C+; Figure  4a,b) at 
their maximum accumulation 24 hours after injury.6 Modestly 
increased monocyte/macrophage numbers at 2 and 5 days after 
injury in φIGF-1 CKO muscle became significant at the 10-day 
time point, 2.7-fold higher in φIGF-1 CKO muscle than those 
in IGFFl/Fl control muscle at the completion of regeneration 
(Figure 4c). At this time point, φIGF-1 CKO macrophage numbers 
maintained high expression of F4/80, which can indicate an acti-
vated state consistent with incomplete regeneration (Figure 4c,d). 
Accumulation of nonmyeloid hematopoetic cells (CD45+CD11b-) 
was also unaffected in φIGF-1 CKO muscle until day 10, when 
their numbers were reduced relative to controls (Figure  4f). 
Monocyte/macrophage viability was similar in φIGF-1 CKO and 
IGFFl/Fl control muscle despite a small yet significant difference at 
day 2 (Figure 4g), indicating that the myeloid ablation of IGF-1 
did not have a large autocrine impact on cell survival.
However, polarization was affected by IGF-1 ablation: at day 
2 after injury significantly more Ly6C+ monocytes/macrophages 
were present in φIGF-1 CKO muscle (Figure 4e), which normal-
ized to control levels by day 5. Impairment in the generation of 
CD206+ macrophages in φIGF-1 CKO was evident at day 5 and 
was more severe at day 10. Reduced CD206+ macrophages at days 
5 and 10 was accompanied by increased numbers of persistently 
activated Ly6C+ inflammatory monocytes/macrophages in  φIGF-
1 CKO muscle, indicating inflammatory skewing in the myeloid 
response to injury.
Compromised gene expression in φIGF-1 CKO 
macrophages
Infiltrating monocytes/macrophages respond to damage signals 
by producing inflammatory cytokines to amplify the inflam-
matory signal and activate repair response. Expression of TNF, 
NOS2, and particularly high levels of IL-1β detected in control 
monocytes/macrophages at day 2 (Figure 5a) were significantly 
increased in φIGF-1 CKO monocytes/macrophages. Expression of 
IL-10, a potent immunosuppressive cytokine that is upregulated 
by activated inflammatory macrophages as part of a self-limiting 
feedback loop to prevent excessive inflammation,35 was increased 
fourfold in φIGF-1 CKO muscle monocytes/macrophages com-
pared to IGFFl/Fl controls at day 2 (Figure  5a), presumably as a 
regulatory response to the increased production of inflamma-
tory mediators in φIGF-1 CKO monocytes/macrophages. This is 
likely the cause of the suppression of Th1 cytokine overproduc-
tion in φIGF-1 CKO monocytes/macrophages observed at day 
5. Consistent with an impaired transition to a reparative phe-
notype, φIGF-1 CKO macrophages expressed significantly less 
TGFβ1, IL-4, and MRC1 at day 5, which was exacerbated at day 
10 (Figure  5b). Expression of Arginase 1 characteristic of IL-4 
induced M2a type polarization was not altered, nor was VEGFα, 
indicating that only selected M2 transcripts are inhibited in the 
absence of IGF-1.
Autocrine loop in bone marrow-derived φIGF-1 CKO 
macrophages
The gene expression changes in φIGF-1 CKO macrophages may 
result from abrogated autocrine IGF-1 signaling which directly 
interferes with macrophage gene expression programs or from 
disrupted cross-talk with IGF-1 responsive cells in the muscle 
bed. To distinguish between these possibilities, we examined 
the response of φIGF-1 KO and IGFFl/Fl BMM cultures to M1 
(IFNγ/LPS) and M2 (IL-4) polarizing stimuli in vitro. Expression 
of inflammatory cytokines NOS2 and IL-6 were significantly 
increased in φIGF-1 CKO BMM (Figure  5c), suggesting that 
autocrine IGF-1 restricts their expression. Interestingly, IL-1β was 
downregulated and TNF was unchanged in φIGF-1 CKO BMM. 
This defines a subset of cytokines repressed by autocrine IGF-1 
in macrophages. Examining gene expression in IL-4 polarized 
macrophages, we observed a clear impairment in the upregula-
tion of M2 products TGFβ1, VEGFα, and MRC1. As in muscle 
macrophages, Arginase 1 was not affected and IL-10 expression 
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was increased in φIGF-1 CKO BMM relative to controls, indicat-
ing that autocrine IGF-1 signaling is required for specific compo-
nents of the M2 gene program.
To determine whether exogenous IGF-1 directly alters gene 
expression, we stimulated BMM with recombinant IGF-1 and 
monitored the induction of M1 and M2 genes by qPCR (Figure 6). 
IGF-1 stimulated expression of the pro-reparative factors IL-4, 
VEGFα, and TGFβ1 characteristic of M2 polarization, whereas 
Arginase 1 was unaffected by IGF-1 stimulation (Figure 6a). In 
contrast, M1-specific genes activated by IFNγ/LPS stimulation 
(IL-1β, NOS2, MMP13; Figure 6b) were significantly repressed in 
the presence of exogenous IGF-1. These results confirm the direct 
effect of IGF-1 on the truncation of inflammation and the induc-
tion of M2 effector molecules in BMM.
DISCUSSION
The importance of macrophage polarization in the resolution of 
tissue injury is well established, but the mechanistic underpin-
nings of this process have not been delineated, impeding thera-
peutic intervention. Here, we document a local transient induction 
of IGF-1 expression by monocytes/macrophages in response to 
muscle injury that regulates myoblast proliferation and myofiber 
Figure 4 Impaired accumulation of CD206+ macrophages in injured φIGF-1 CKO mice. (a) Representation of the gating strategy used to identify 
monocytes (CD45+CD11b+Ly6G-Ly6Chi) and neutrophils (CD45+CD11b+Ly6G+). (b) Monocyte and neutrophil recruitment to quadricep muscles 
of φIGF-1 CKO mice, and IGF-1Fl/Fl controls was measured 1 day after CTX injury. (c) Accumulation of macrophages (CD45+CD11b+F4/80+) was 
quantified at 2, 5, and 10 days. (d) Histogram showing F4/80 expression on φIGF-1 CKO (red line) and IGF-1Fl/Fl control (blue line) macrophages 
(CD45+CD11b+F4/80+) isolated 10 days after injury or from uninjured muscle. (e) To follow changes in macrophage phenotypes, the proportion of 
Ly6C+ monocytes/macrophages and CD206+ macrophages were measured at 2, 5, and 10 days after CTX injury in φIGF-1 CKO and control muscle. 
(f) Accumulation of nonmyeloid hematopoietic cells (CD45+CD11b-) in injured muscle. (g) Viability of cells isolated from injured muscle showed 
was determined using a ViCell counter. Data represent mean ± SEM of 4–5 mice. *P ≤ 0.05; ** P ≤ 0.01 compared to IGF-1Fl/Fl by Mann–Whitney test.
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growth, in that inactivation of the IGF-1 gene in monocytes/mac-
rophages was associated with a decrease in myoblast numbers and 
a striking reduction in myofiber CSA. The same phenotype has 
been documented in damaged muscle with abrogation of IGF-1 
signaling by administration of a neutralizing antibody17 or dele-
tion of the IGF-1 receptor in satellite cells.36 In the absence of 
monocyte/macrophage IGF-1 expression, whole muscle IGF-1 
levels were restored by the later stages of regeneration but without 
correcting aberrant muscle architecture and fat deposition. Taken 
together, these observations underscore a role for  monocyte/mac-
rophage-derived IGF-1 in orchestrating the early events of muscle 
regeneration.
These data also point to promotion of skeletal muscle regen-
eration by monocytes/macrophages through fiber hypertrophy at 
the expense of hyperplasia, as reduced fiber CSA in φIGF-1 CKO 
muscle by day 10 was accompanied by a net increase in the aver-
age number of nuclei associated with each regenerated fiber. In 
contrast, muscle-specific IGF-1R deletion reduced both the num-
ber of nuclei per fiber and fiber CSA after injury,34 suggesting 
that residual IGF-1 expressed by other cell types in the φIGF-1 
CKO muscle was sufficient to maintain satellite cell proliferation 
and myoblast fusion. It also likely that monocytes/macrophages 
secrete additional growth-promoting factors in response to auto-
crine IGF-1 that are necessary for full recovery of muscle mass 
after injury. Taken together, the two studies are in accordance 
with the idea that monocytes/macrophages are both an important 
source of IGF-1 in muscle regeneration, stimulating muscle repair 
directly as well as indirectly through autocrine feedback loops.
Myeloid deletion of IGF-1 also causes changes in monocyte/
macrophage dynamics, observed as a bias toward Ly6C+ mono-
cytes/macrophages. These results highlight a productive autocrine 
loop that reinforces the progression from inflammation to the 
resolution of muscle damage. IGF-1 targets key genes in the polar-
ization program as macrophages lacking IGF-1  (φIGF-1 CKO) 
exhibited altered gene expression programs, exaggerated inflam-
matory gene expression (TNF, IL-1β, and NOS2). In isolated mac-
rophage cultures a similar pattern of increased inflammation and 
hindered expression of pro-reparative mediators was observed, 
confirming an autocrine role for IGF-1. Although the immu-
nosuppressive nature of IGF-1 has been documented (reviewed 
in ref. 37), its action on macrophage polarization has not been 
previously reported. The normal surge in IGF-1 expression in 
Figure 5 Dysregulated inflammatory gene expression in φIGF-1 CKO monocytes/macrophages. (a, b) Monocytes/macrophages were FACS 
isolated from injured φIGF-1 CKO muscle at days 2, 5, and 10 days after induction of CTX injury for gene expression analyses. (a) Inflammatory gene 
expression was measured in the cells at 2 and 5 days after injury corresponding to peak expression. (b) Expression of M2 genes was measured in 
isolated φIGF-1 CKO monocytes/macrophages 5 and 10 days after injury and compared to IGF-1Fl/Fl controls. (c) BMM were prepared from φIGF-1 
CKO and IGF-1Fl/Fl and analyzed for gene expression changes by qPCR. For the measurement of inflammatory M1 genes, BMM were polarized with 
IFNγ/LPS. For the measurement of M2 genes, BMM were stimulated with IL-4 for 12 hours. Data represent mean ± SEM of six tests. For cell isolation 
experiments, n = 4; *P ≤ 0.05, **P ≤ 0.01 compared to IGF-1Fl/Fl by Mann–Whitney test. BMM, bone marrow–derived macrophages.
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injured muscle coincides with the transition from inflammatory 
monocytes/macrophages to reparative macrophages and likely 
reinforces the progression to tissue healing by suppressing inflam-
mation and inducing M2 genes previously implicated in the reso-
lution phase of muscle regeneration.3,38 It is possible that IGF-1 
also alters the balance between macrophage phenotypes by regu-
lating the trafficking of specific subsets; however, this has not been 
addressed in our study.
As in other tissues, the temporal sequence of different macro-
phage populations in skeletal muscle is presumably tied to differ-
ent requirements at the various phases of tissue repair. Although 
it remains to be elucidated how IGF-1 expression is regulated 
in macrophages during skeletal muscle repair, its induction is 
independent of the polarization state: intramuscular Ly6C+ and 
CD206+ monocytes/macrophages produced similar amounts of 
IGF-1Ea and IGF-1Eb propeptide, each with its own expression 
pattern. These results concur with the findings of Lu et al.6 who 
reported high levels of IGF-1 expression in both Ly6C- and Ly6C+ 
macrophages, although more prominently by the Ly-6C-subset, 
measured at a single time point after barium chloride injury. Our 
observations run counter to the accepted paradigm in which high 
production of IGF-1 is considered a feature of M2 polarization. 
This conclusion is based on in vitro data,39,40 which do not ade-
quately model the complex kinetics of macrophage activation 
states in vivo, resulting from multiple interacting cues. Indeed, 
colocalization of IGF-1 with Arginase 1 but not IL-10 expression 
in lung macrophages was not accompanied by direct comparison 
to inflammatory macrophages.25
Macrophages present in diseased and regenerating mus-
cle are heterogeneous with distinct gene programs regulating 
their diverse functions.41,42 IGF-1 administered to BMM in vitro 
induced upregulation of IL-10 and TGFβ1 and hindered expres-
sion of inflammatory mediators such as NOS2 and IL-1β, similar 
to the polarization achieved in vitro by IL-10, TGFβ1 stimulation, 
or interaction with Treg cells.11,43 Referred to as wound healing 
or M2c macrophages, these are associated with the resolution 
phase of regeneration42 and are involved in the termination of 
inflammation, support of angiogenesis and reinstatement of 
homeostasis. A similar phenotype is observed in mature resident 
macrophages44; however, the relationship between the two has 
not been specifically studied in skeletal muscle. In contrast, an 
alternative M2 phenotype, M2a, is described to produce IL-4 and 
Arginase 1 that block the production of NOS2 and promote the 
production of ornithine and polyamines, a phenotype not directly 
Figure 6 Macrophage gene regulation by IGF-1 in vitro. (a) Bone marrow–derived macrophages were stimulated with mature, recombinant IGF-1 
for 12 hours and expression of M2 genes assessed by qPCR. Treatment with IL-4 was performed for comparison. *P ≤ 0.05, for IGF-1-treated cells 
compared to unstimulated cells. (b) Macrophages M1 polarized with LPS and IFNγ were subsequently exposed to recombinant IGF-1 for 8 hours and 
inflammatory gene expression evaluated by qPCR, normalized to GAPDH. *P ≤ 0.05, for IGF-1/IFNγ-treated cells compared to IFNγ-treated cells. Data 
represent mean ± SEM of six tests.
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induced by IGF-1, although its suppression of inflammatory sig-
nals may also allow for further polarization of macrophages by 
other M2-inducing stimuli in the regenerating muscle bed.
Research on the IGF-1Eb propeptide has heretofore been 
restricted to ex vivo or overexpression experimentation.45 
Enhanced skeletal muscle satellite cell activation and prolifera-
tion has been ascribed to a derivative synthetic 24aa Eb peptide 
moiety referred to as MGF,46 which has not been detected in vivo. 
Moreover, the mitogenic effects of synthetic MGF in vitro are con-
tested,19,29,47,48 and it remains unclear whether an equivalent pep-
tide is derived from cleavage of endogenous IGF-1Eb propeptide. 
Although genetic deletion of IGF-1Eb had negligible effects on 
muscle regeneration in vivo, it might promote tissue growth in 
other physiological contexts.
Our results do not rule out the role of other myeloid cell types 
at earlier time points in muscle regeneration. As Cre-mediated 
deletion of the IGF-1 gene locus was driven by a LysM promoter, 
which is expressed in neutrophils present within 24 hours after 
injury,32,33 we cannot rule out their early contribution to the IGF-1 
pool in regenerating muscle. However, as these cells are present 
in relatively low numbers at the time points used in the study (2, 
5, and 10 days) reduction of IGF-1 expression in injured φIGF-1 
CKO muscle is largely attributable to monocytes/macrophages. 
Indeed, several studies have blocked the recruitment of macro-
phages to injured muscle and regardless of the method employed, 
myofiber growth was retarded, regeneration was impaired, and 
was typically associated with fat deposits and reduced local IGF-1 
levels.6,49
What is the likely source of IGF-1 late in regeneration, present 
even in φIGF-1 CKO muscle? IGF-1 is highly expressed by inter-
stitial fibroblasts, which expand in numbers at this time and are 
known to be high producers of IGF-1 in other tissues.50 Although 
macrophage-derived IGF-1 induces myofibroblast activation and 
proliferation in vitro,51 fibroblast numbers were not reduced in the 
φIGF-1 CKO setting and may be the main source of IGF-1 at the 
10 day time point. Additionally, myoblasts upregulate IGF-1 as 
they differentiate so the maturing myofibers and may be a signifi-
cant source of IGF-1 as the muscle returns to homeostasis.
Our findings have important clinical implications for regen-
erative medicine. Current treatments for diseases with a high 
inflammatory burden, such as muscular dystrophy, could lead to 
indiscriminate macrophage depletion, compromising resolution 
of tissue damage. Macrophages have been cited as protagonists of 
tissue inflammation and repair in cardiovascular disease, working 
in organ networks that can lead to derailed infarct healing exac-
erbated by age-related comorbidity factors that is unlikely to ben-
efit from broad immunosuppressive regimes. Rather, a controlled 
modulation of immune function will be required to achieve the 
physiological stability required for durable prevention of disease 
progression. Thus, monocyte/macrophage IGF-1 represents a 
potentially powerful point of clinical intervention for modulation 
of aberrant immune responses in a variety of degenerative diseases.
MATERIALS AND METHODS
Animals.  Mice were housed in a clean, temperature controlled (22 °C) 
mouse facility and maintained on a 12 hour light/dark cycle with free access 
to standard chow and drinking water. Mice were sacrificed by asphyxiation 
with CO2 and cervical dislocation. If blood samples were taken, the mice 
were anesthetized, the chest was opened then blood was taken directly 
from the heart and kept at 4 °C over night. Blood serum was separated 
by centrifugation of blood samples (4 °C, 14,000 rpm for 20 minutes) and 
stored at −80 °C until needed. All animal experiments were approved by the 
European Molecular Biology Laboratory Monterotondo Ethical Committee 
and were in accordance with national and European regulations.
Generation of IGF-1 floxed alleles.  Homologous recombination was 
used to insert LoxP sites flanking exon 3 (gene ablation)31 or exon 5 
(IGF-1Eb propeptide) of the IGF-1 gene using RecE-RecT recombina-
tion (Figure 1a). A LoxP-flanked PGK-neomycin-resistence cassette was 
inserted 5′ of exon of interest, used for selection and later removed by elec-
troporating positive clones with a Cre-recombinase-expressing plasmid, 
leaving a single 5′ LoxP site. The FRT-flanked PGK-neomycin-resistence 
cassette and an additional LoxP site were inserted 3′ of the targeted exon. 
Each targeting construct was confirmed by sequencing analysis.
Generation of IGF-1 knockout mice.  To generate the conditional macro-
phage IGF-1 knockout (φIGF-1 CKO), mice carrying a floxed exon 3 allele 
(46) were crossed with the myeloid-specific LysM-Cre line32 (on a C57/Bl6 
background) and further crossed to obtain ubiquitous homozygous dele-
tion of the targeted exon. To generate the IGF-1Eb KO, at least two cor-
rectly targeted ES cell clones per construct were microinjected into C57/
Bl6 J host blastocysts to obtain chimeric mice. Chimeric males were mated 
to C57/Bl6 J females and germline transmission of the mutated allele to 
their offspring was confirmed by PCR and Southern blotting analysis. Mice 
carrying floxed exon 5 allele were crossed with the ubiquitous CMV-Cre 
line52 (on a C57/Bl6 background) and further crossed to obtain ubiquitous 
homozygous deletion of the targeted exon. For both IGF-1 floxed alleles, 
no phenotypic differences were observed in two independently generated 
lines. For most experiments, LysM-Cre mice were included as controls, 
with no discernable phenotype.
IGF-1 serum concentration measurements. To determine circulating 
IGF-1 levels, the OCTEIA Rat/Mouse IGF-1 IEMA for the quantitative 
determination of IGF-1 in rat and mouse serum was used (iDS, Boldon, 
UK) according to the manufacturer’s instructions. Results were calculated 
by logarithmic plotting of the mean absorbance of each calibrator against 
concentration of rat IGF-1 calibrators.
Muscle regeneration.  Mice were anesthetized with isofluorane and the 
TA and quadriceps from 2–3-month-old mice were injected with 4 and 8 
injections of 5 µl CTX, respectively (Latoxan, Valence, France, diluted to 
10 µmol/l in phosphate buffered saline (PBS). Muscle samples were taken 
various times postinjury. For histology, at least three mice were analyzed 
per time point, while 4–8 mice were analyzed per time point for flow 
cytometry and cell sorting experiments.
BMM culture. Femurs and tibiae were collected from mice then crushed in 
the presence of PBS + 1% fetal bovine serum (FBS), filtered through a 70 
μm filter (BD Bioscience, Oxford, UK) and pelleted. The bone marrow cells 
were plated on plastic tissue culture dishes at a density of 1.5 × 106 cells/10 cm 
dish in RPMI medium supplemented with 20 ng/ml macrophage colony-
stimulating factor (Sigma, St Louis, MO) and 50 µmol/l β-mercaptoethanol 
for 6 days to derive macrophages. M-CSF was reduced to 10 ng/ml for 12 
hours then depleted from the medium for another 12 hours and serum 
reduced to 2%. Stimulation of macrophages was performed with 50 ng/ml 
rIGF-1 (Peprotech, Rocky Hill, NJ) or 5 U/ml IL-4 (Peprotech) for 8 hours 
before RNA isolation. Some cells were treated overnight with 100 U/ml IFNγ 
(Peprotech) then for 4 hours with 100 U/ml IFNγ + 1 µg/ml LPS (Sigma) 
before stimulation with rIGF-1 for 8 hours. For RNA isolation, cells were 
washed in PBS and lysed in TRIzol Reagent (Invitrogen, Carlsbad, CA).
RNA isolation. Total RNA was extracted from snap-frozen tissues and cul-
tured cells with TRIzol Reagent (Invitrogen) according to the manufac-
turer’s instructions. For FACS-sorted cells total RNA was prepared using 
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the RNeasy micro and mini kits (Qiagen, Manchester, UK), depending on 
the number of isolated cells.
Quantitative PCR. cDNA was prepared from 1 µg of RNA with a Quantitect 
reverse transcription kit (Qiagen). Quantitative PCR was performed 
with Taqman probes run on the 7500 real-time RT-PCR system (Life 
Technologies, Monza, Italy) and quantified by the delta ΔcT method nor-
malized to house keepings genes as indicated. Taqman primer and probe 
sets were as follows: Arg1, Mm00475988_m1; mouse ACTB (actin beta) 
endogenous control; Csf1, Mm00432686_m1; Emr1, Mm01233106_m1; 
mouse GAPDH endogenous control; IGF-1Ea, Mm00710307_m1; IGF-1Eb, 
Mm01228180_m1; total IGF-1; IL-1b, Mm01336189_m1;  Mm-00439560_
m1; IL-4, Mm00445259_m1; IL-10, Mm00439614_m1; IL-12p40, 
Mm00434174_m1; MRC1, Mm03024053_m1; NOS2, Mm01288989_
m1; TGFβ1, Mm00485148_m1; TNF, Mm00443258_m1; Rps20, 
Mm02342828_g1; VEGFα, Mm00437306_m1; YM1, Mm04213363_u1; 
Cre, custom primers and probe, For - GCG GTC TGG CAG TAA AAA CTA 
TC Rev - GTG AAA CAG CAT TGC TGT CAC TT Probe - AAA CAT GCT 
TCA TCG TCG GTC CGG.
Histology.  For paraffin sections, tissues were fixed in 4% paraformal-
dehyde for 30 minutes, dehydrated in series of ethanol dilutions, passed 
though xylene, xylene/paraffin, and embedded in paraffin. Transverse 
cross sections were cut at 8 µm and stained with Trichrome (Sigma, Dorset, 
UK). Morphometric analysis was performed on digital images taken by a 
camera (Nikon DXM 1200F) connected to a Leica PM RBE microscope. 
Nonoverlapping images were taken of the entire cross-sectional area of the 
muscle using ImagePro Plus 4.0 (Microsoft) software and tiled to recon-
stitute the whole image of the muscle. CSA was measured by tracing indi-
vidual myofibers using FIJI.
Cell Isolation and flow cytometry.  For cell isolation from tissue, injured 
muscles were placed in warmed DMEM (Life Technologies, Paisley, 
UK), and matrix, fibrotic tissue, and nerves were removed carefully. The 
muscles were chopped into small pieces and enzymatic disaggregation 
was performed, first using freshly prepared 4 mg/ml collagenase type II 
(Worthington, Lakewood, NJ) for 30 minutes (37 °C), then using 1 mg/
ml collagenase/dispase (Roche, West Sussex, UK) for 20 minutes (37 °C). 
Disaggregation was stopped with 5ml of ice-cold horse serum (heat- 
inactivated; Life Technologies, Paisley, UK) and cells filtered through a 
40  µm cell strainer (BD Bioscience). For blood cell isolation, the blood 
was collected in  heparin-coated tubes and red blood cells lysed with Geys 
solution. An aliquot of the cell suspension was used for cell quantitation on 
a ViCell counter (Beckman Coulter). Isolated cells were mixed with cold 
PBS plus 1% FCS (Gibco) and blocked with purified anti CD16/32 (eBio-
science, Hatfield, UK) for 10 minutes on ice. For monocyte/macrophage 
analysis and sorting, cells were stained with the following antibodies for 
10 minutes on ice:  CD45-APC/Cy7 (eBioscience), CD11b-PE (eBiosci-
ence), F4/80-biotin (AbD serotec, Kidlington, UK), Ly6C-APC (eBiosci-
ence), and CD206-Alexa 488 (Biolegend, London, UK). The macrophage 
population was very heterogeneous with only a proportion expressing 
Ly6C or CD206. For analysis of monocyte and neutrophil populations cells 
were stained with CD45-APC/Cy7, CD11b-PE, F4/80-biotin,  Ly6C-APC 
and Ly6G-FITC (eBioscience). To distinguish other cell populations in 
the muscle, a combination of CD45-APC/Cy7,  a7b1-integrin-PE (RnD 
Systems, Abingdon, UK) and CD31-PerCPCy5.5 (Biolegend) were used. 
For biotinylated antibodies Streptavidin-PECy7 (eBioscience) was used as 
a secondary reagent. Sytox blue (Invitrogen) was used to exclude dead cells 
and debris and isotype controls used to set gates. Samples were acquired 
with a FACSCalibur and analyzed with FlowJo software (Tree Star, Ashland, 
OR). To quantitate the absolute number of a defined cell population, the 
percentage of the defined population out of the total number of live cells 
(determined by Sytox blue exclusion) was divided by 100 and multiplied by 
the viable cell count for that sample taken on the ViCell counter. This was 
divided by the muscle weight for that sample for normalization. For gene 
expression analysis, cells were sorted directly into RLT Buffer (Qiagen).
Statistical analysis. Statistical analyses were performed with GraphPad 
Prism 5 software (GraphPad Software, San Diego, CA). Data are expressed 
as ± SEM. For comparison of two groups, the Mann–Whitney U-test was 
performed and differences considered significant if P < 0.05. N numbers 
are specified in the figure legends. The growth curve in Supplementary 
Figure S4b was analyzed with a  two-way paired analysis of variance test.
SUPPLEMENTARY MATERIAL
Figure S1. Cellular sources of IGF-1 in regenerating muscle.
Figure S2. Gating strategies and FMO controls used to define mono-
cytes/macrophages isolated from muscle.
Figure S3. IGF-1Eb propeptide is dispensable for muscle 
regeneration. 
Figure S4. Specificity of Lysozyme M Cre-mediated deletion of IGF-1.
Figure S5. Phenotype of mice with myeloid-specific deletion of IGF-1.
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